Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer

Cancer Genetics and Cytogenetics

Volumn 93, Issue 2, 1997, Pages 167-171

  Eydmann, Marian E ^a   Knowles, Margaret A ^a  

^a MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ARTICLE; BLADDER CANCER; CHROMOSOME 8P; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; TUMOR CELL CULTURE;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; GENES, TUMOR SUPPRESSOR; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030937872     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00200-2     Document Type: Article

References (38)

1. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law M (1994): Allelotype of human bladder cancer. Cancer Res 54:531-538.
2. Knowles MA, Shaw ME, Proctor AJ (1993): Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364.
3. Takle LA, Knowles MA (1996): Deletion mapping implicates two tumour suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene 12:1083-1087.
4. Sandberg AA, Berger CS (1994): Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 151:545-560.
5. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989): Allelotype of colorectal carcinomas. Science 244:207-211.
6. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992): Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 52:5368-5372.
7. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991): Deletion mapping on chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
8. Bova SG, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB (1993): Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
9. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y (1993): Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53:1172-1174.
10. Kelemen PR, Yaremko ML, Kim AH, Montag A, Michelassi F, Westbrook CA (1994): Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma. Genes Chromosom Cancer 11:195-198.
11. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, Miyaki M, Monden M, Nakamura Y (1993): Allelic loss at chromosome hand 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosom Cancer 7:152-157.
12. Cannizzaro LA, Bollum FJ, Huebner K, Croce CM, Cheung LC, Xu X, Hecht BK, Chang LMS (1988): Chromosome sublocalization of a cDNA for human DNA polymerase-β to 8p11→p12. Cytogenet Cell Genet 47:121-124.
13. Wang TSF (1991): Eukaryotic DNA polymerases. Ann Rev Biochem 60:513-552.
14. Jones TA, Barker HM, da Cruz e Silva EF, Mayer-Jaekel RE, Hemmings BA, Spurr NK, Sheer D, Cohen PTW (1993): Localization of the genes excoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23→q31 and 8p12→p11.2, respectively. Cytogenet Cell Genet 63:35-41.
15. Cohen P (1989): The structure and regulation of protein phosphatases. Ann Rev Biochem 58:453-508.
16. Cohen P, Holmes CFB, Tsukitani Y (1990): Okadaic acid: A new probe for the study of cellular regulation. TIBS 15:98-102.
17. WHO (1973): Histological typing of urinary bladder tumours. In: International Histological Classification of Tumours, vol 10, Geneva: WHO.
18. UICC (1978): TNM classification of malignant tumors, bladder. Union Internationale Contre le Cancer, Geneva, pp 113-117.
19. Evans DR, Irwin RJ, Havre PA, Bouchard JG, Kalo T, Prout GR (1977): The activity of the pyrimidine biosynthetic pathway in MGH-U1 transitional carcinoma cells grown in tissue culture. J Urol 117:712-719.
20. Rigby CC, Franks LM (1970): A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer 24:746-754.
21. Rasheed S, Gardner MB, Rongey RW, Nelson-Rees WA, Arnstein P (1977): Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst 58:881-890.
22. Paulie S, Hansson Y, Lundblad ML, Perimann P (1983): Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Internat J Cancer 31:297-303.
23. Grossman HB, Wedemeyer G, Rem L, Wilson GL, Cox B (1986): Improved growth of human urothelial carcinoma cell cultures. J Urol 136:953-959.
24. Williams RD (1980): Human urologic cancer cell lines. Invest Urol 17:359-363.
25. Elliot AY, Cleveland P, Cervenka J, Castro AE, Stein N, Hakala TR, Fraley EE (1974): Characterization of a cell line from human transitional cell cancer of the urinary tract. J Natl Cancer Inst 53:1341-1349.
26. Kyriazis AA, Kyriazis AP, McCombs (III) WB, Peterson WBJ (1984): Morphological, biological and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture. Cancer Res 44:3997-4005.
27. O'Toole C, Nayak S, Price Z, Gilbert WH, Waisman J (1976): A cell line (SCaBER) derived from squamous cell carcinoma of the human urinary bladder. Int J Cancer 17:707-714.
28. Kieler JF (1984): Invasiveness of transformed bladder epithelial cells. Cancer Metastasis Rev 3:265-296.
29. Knowles MA, Williamson M (1993): Mutation of H-ras is infrequent in bladder cancer: Confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 53:133-139.
30. Englander EW, Wilson SH (1990): Protein binding elements in the human β-polymerase promoter. Nucl Acids Res 18:919-928.
31. Widen SG, Kedar P, Wilson SH (1988): Human β-polymerase gene. J Biol Chemistry 263:16992-16998.
32. Khew-Goodall Y, Meyer RE, Maurer F, Stone SR, Hemmings B (1991): Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. Biochemistry 30:89-97.
33. Wang L, Patel U, Gosh L, Banerjee S (1992): DNA polymorphism β mutations in human colorectal cancer. Cancer Res 52:4824-4827.
34. Chyan Y-J, Ackerman S, Shepherd NS, McBride OW, Widen SG, Wilson SH, Wood TG (1994): The human DNA polymerase β gene structure. Evidence of alternative splicing in gene expression. Nucl Acids Res 22:2719-2725.
35. Dobashi Y, Shuin T, Tsuruga H, Uemura H, Torigoe S, Kubota Y (1994): DNA polymerase β gene mutation in human prostate cancer. Cancer Res 54:2827-2829.
36. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R (1994): Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromosom Cancer 10:151-159.
37. Herman JG, Latif F, Lerman MI, Zbar B, Liu S, Samid D, Duan D-SR, Gnarra JR, Linehan WM, Baylin SB (1994): Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
38. SenGupta DN, Zmudzka BZ, Kumar P, Cobianchi F, Skowronski J, Wilson SH (1986): Sequence of human DNA polymerase β mRNA obtained through cDNA cloning. Biochem Biophys Res Commun 136:341-347.